LASR / RESEARCH · ↑ INDEX 2026-05-01
Silent Engineering Fund
May 01, 2026
LASR
nLIGHT, Inc.
Analysis Date: 2026-05-01 Exchange: NASDAQ Sector: Technology · Semiconductors
HOLD

nLIGHT makes the high-energy fiber-laser modules that feed Iron Beam — Rafael's 100kW-class directed-energy interceptor that went operational in Israeli air-defense deployments in late 2025 — and it is the only Western supplier that fabricates its own semiconductor laser diodes, fiber lasers, beam combiners, and integrated weapon-grade systems under one roof. That vertical stack is what got nLIGHT into HELIOS Block 2, IFPC-HEL, and the JCO directed-energy programs while integrators who source diodes externally eat margin on every module. The moat compounds through qualification cycles that run 12-24 months per customer per diode and through a $162M funded backlog plus $184M of unfunded U.S. government contracts — roughly $346M of visibility against a ~$280M FY26 revenue base. The cutting/welding exit masks the A&D inflection: a -$25-30M revenue headwind will compress the FY26 headline print while A&D segment revenue grew ~50% YoY in 2025, which means the Street has to read past the sequential decline to see the acceleration. Six sessions from now, the Q1 print will confirm or break the book-to-bill walk — three consecutive quarters above 1.0x is the institutional bar for a defense-contractor inflection, and four quarters would lock it.

Portfolio Decision

Maintain LASR exposure at <= 1.5% NAV at $69.85

ahead of the 2026-05-07 Q1 2026 earnings release with a hard stop at

$63.43 (2026-04-29 intraday low). The setup is institutionally clean

but binary: A&D book-to-bill walked from 0.95x to 1.18x across 2025

and funded backlog grew 47% to $162M, but the equity is priced at 138x

forward earnings with $9.3M of insider distribution in the past 6

months and zero open-market buys. With 6 trading sessions to a

high-impact catalyst, the right call is to preserve optionality

without taking disproportionate event risk. Conditional upgrade to

Overweight (2.5% NAV) only on confirmed Q1 A&D segment revenue > $52M

AND funded backlog > $165M AND FY2026 guide reiterated as "total

revenue growth or better."

nLIGHT has spent 2025 narrowing into a focused

A&D growth engine (HELIOS, IFPC-HEL, JCO directed-energy, Israel Iron

Beam) supported by a vertically integrated semiconductor laser diode

fab in Vancouver, WA — a moat competitors (Coherent, Lumentum, IPG

Photonics) do not own. The Q4 2025 print delivered the most decisive

inflection evidence of the cycle: revenue $81.2M (+67% YoY), gross

margin 30.7% (+260 bps YoY), adjusted EBITDA $10.7M (vs -$17M Q4 2024),

operating cash flow $17.5M (vs -$3.9M Q4 2024). The FY2025 funded

backlog of $162M plus $184M of unfunded U.S. government contracts

provides ~$346M total visibility against a ~$280M FY2026 implied

revenue base. The Longmont, CO 50,000 sq ft expansion (announced

2026-01-30, capacity online late 2026) prepares the company for the

FY27 directed-energy program ramp tied to DoD POM submission and

Congressional NDAA passage in late 2026.

The bull case clears all 5 items of the Specificity Bar with substantive

evidence (per the SEF research checklist enforcement protocol). The

bear case is also substantive: 138x forward P/E with negative equity

risk premium math, a -21% drawdown in 4 sessions immediately preceding

the print (which is the market starting to price in the cutting/welding

exit headwind), and historical precedent for 138x P/E single-stock

defense names that miss earnings (AVAV -45%, KTOS -35%, PLTR -32%).

The kill-switch threshold debate — bull argues A&D revenue < $50M

(too low — Q4 was $48M), bear argues > $55M with backlog > $170M (too

high) — settles at the plan's > $52M AND backlog > $165M as the

acceleration test. The risk-debate triangulation arrives at Kelly-

optimal sizing of 1.3-2.0% NAV, with the plan's 1.5% NAV maintenance

sitting at the conservative end of optimal — appropriate for the

negative-skew binary.

The prior cross-ticker memory (AAPL Hold, +3.7% over 5 days vs SPY

+1.7%, alpha +2.1%) supports the disciplined Hold approach for

high-conviction setups with binary catalyst proximity: maintaining

exposure with appropriate stops captures upside on a clean print

without overcommitting to event risk.

Quantitative Lane

Customer Concentration

Customer Concentration (LASR 10-K Item 1A & MD&A, FY2025)

Top customer disclosure (estimated from 10-K Item 1A and Q4 2025 earnings call commentary):

Customer (or proxy)Estimated % of RevenueSegmentRead
U.S. Government (DoD) via prime contractors~50-55%A&D directed energy + sensingConcentration vector #1
Lockheed Martin (HELIOS, IFPC-HEL)~15-20%A&DLargest single named prime
Raytheon Technologies (DEW programs)~10-15%A&DSecond-largest prime
Northrop Grumman / General Atomics~5-10%A&DSmaller program exposure
Israeli MoD via Rafael (Iron Beam)~5-10%A&D internationalIron Beam catalyst
Semiconductor / advanced manufacturing OEMs~10-15%MicrofabricationKLA, Applied Materials, ASML adjacent
Discrete medical / industrial sensing customers~5-10%SensingDiversified

Key takeaways:

  • Top 5 customers account for approximately 60-70% of revenue (industry

norm for defense supplier).

  • The U.S. government (direct + via primes) is the single largest end

customer; concentration risk is high but accompanied by long-cycle

contract visibility ($162M funded + $184M unfunded = ~$346M total

backlog visibility).

  • International A&D is concentrated on Israel (Rafael / Iron Beam) and

allied NATO partners — geopolitical-event-sensitive but currently

tailwind.

  • Industrial cutting/welding exit removes ~$25-30M of legacy customer

exposure (largely diversified mid-tier industrial OEMs).

  • Microfabrication exposure concentrated in advanced-node photolithography

toolmakers (KLA, AMAT, ASML); near-term cooling at legacy nodes.

Source: LASR FY2025 10-K Item 1A "Customer Concentration" disclosure

+ Q4 2025 earnings call commentary (2026-02-26). Specific named

customer percentages are not separately disclosed in the 10-K beyond a

threshold (typically 10%); the table above blends 10-K disclosure with

public program-funding documents (DoD R-1 line items, Israeli MoD

budget transparency reports) and primer-contractor 10-K disclosures

mentioning nLIGHT as a sub-supplier.

Backlog & Book-to-Bill
Channel Checks
  • Lockheed Martin HELIOS Block 2 production progressing (CEO commentary 2026-02-26)pass
  • IFPC-HEL prototype contract awarded to Raytheon late 2025; nLIGHT confirmed sub-supplierpass
  • Israel Iron Beam: Rafael production ramp; nLIGHT high-power laser modules sole source per Israeli MoD refmarginal
  • Longmont CO 50,000 sq ft expansion announced 2026-01-30; capacity online late 2026marginal
  • $201M follow-on offering Feb 2026 explicitly tagged for working capital and capital projectsmarginal
  • Cutting/welding exit announced; $25-30M revenue headwind FY2026 frontloaded Q1fail
  • Q1 2026 guide $70-76M = -10% sequential due to industrial exit; A&D growth impliedpass
QuarterBacklogBook-to-Bill
Q1 20250.95x
Q2 20251.05x
Q3 20251.10x
Q4 20251.18x

**Book-to-bill trend is the single most important forward read.** The implied A&D book-to-bill walks 0.95 → 1.05 → 1.10 → 1.18 across 2025 — three consecutive quarters above 1.0x is the institutional bar for confirming a defense-contractor inflection (per the Trail of Bits / SEF research checklist). The funded backlog grew +47% ($110M → $162M) while A&D segment revenue grew ~50% YoY. The May 7 Q1 2026 print needs to confirm a 4th consecutive quarter of >1.0x book-to-bill (implied A&D bookings >$50M against $50M+ A&D revenue) to validate the multi-year inflection thesis. The cutting/welding exit creates an asymmetric read: the 2026 headline number will compress -10% sequentially in Q1 due to industrial wind-down, but A&D segment growth must be the offsetting data point. If A&D bookings disappoint OR funded backlog declines, the re-rating risk is substantial given the 138x forward P/E.

Catalyst Calendar
CATALYST TIMELINE Q2 2026 2026-05-07 Q1 2026 Earnings Release (After Market Close) HIGH 2026-05-07 Q1 2026 Earnings Conference Call (5:00 PM ET) HIGH 2026-05-12 Citi Industrials Conference (potential) MED 2026-Q2 DoD FY2027 Budget House Markup HIGH Q3 2026 2026-08-05 Q2 2026 Earnings Release HIGH 2026-Q3 DoD FY2027 Budget Senate Markup HIGH 2026-Q3 Longmont CO 50,000 sq ft expansion completion MED 2026-Q3 Israel Iron Beam program milestones HIGH Q4 2026 2026-11-04 Q3 2026 Earnings Release HIGH 2026-Q4 DoD FY2027 NDAA conference / passage HIGH 2026-Q4 HELIOS Block 2 production milestones HIGH Q1 2027 2027-02 Q4 2026 / FY2026 Earnings Release HIGH 2027-02 Form 10-K filing FY2026 MED

Catalyst nodes are color-coded by impact (red=high, amber=medium, tan=low). Events grouped by quarter in the table below.

DateEventImpact
2026-Q2
2026-05-07Q1 2026 Earnings Release (After Market Close) — Binary 6-day catalyst; revenue $70-76M guide; A&D book-to-bill confirmation neededHigh
2026-05-07Q1 2026 Earnings Conference Call (5:00 PM ET) — Management commentary on 2026 A&D growth; cutting/welding exit progress; backlog detailHigh
2026-05-12Citi Industrials Conference (potential) — Post-print investor outreach; sub-supplier capital allocation Q&AMedium
2026-Q2DoD FY2027 Budget House Markup — Directed-energy line items in FY27 House Defense Appropriations Subcommittee markupHigh
2026-Q3
2026-08-05Q2 2026 Earnings Release — First post-cutting/welding-exit clean quarter; A&D growth visibilityHigh
2026-Q3DoD FY2027 Budget Senate Markup — Senate Armed Services Committee defense authorization; outyear DEW funding visibilityHigh
2026-Q3Longmont CO 50,000 sq ft expansion completion — Capacity online; supports 2027 high-energy laser deliveriesMedium
2026-Q3Israel Iron Beam program milestones — Initial deployment; nLIGHT module deliveries against Rafael contractHigh
2026-Q4
2026-11-04Q3 2026 Earnings Release — Pre-FY27 visibility; 2027 preliminary guideHigh
2026-Q4DoD FY2027 NDAA conference / passage — Final defense bill; locks-in directed-energy program funding for FY27High
2026-Q4HELIOS Block 2 production milestones — LMT prime contractor production progress; LASR delivery against funded backlogHigh
2027-Q1
2027-02Q4 2026 / FY2026 Earnings Release — Full-year results vs guidance; FY27 guideHigh
2027-02Form 10-K filing FY2026 — Audited financials; risk factor updates on cutting/welding exit completionMedium

Research Manager

Investment Plan — Hold

Rationale:

The bull case clears all five items of the Bull-Case

Specificity Bar with substantive, verifiable evidence — two dated

catalysts (2026-05-07 Q1 print + 2026-Q2 DoD FY27 House Markup),

quantitative TAM math (DoD directed-energy TAM walk + LASR share

estimates with explicit haircut), an explicit budget-cycle reference

(POM submission and Congressional markup timing), a concrete capacity

event (Longmont CO 50,000 sq ft expansion announced 2026-01-30), and a

falsifiable kill-switch (A&D revenue < $50M AND backlog decline below

$155M = thesis broken). Per the Specificity Bar enforcement protocol,

this means no automatic downgrade applies. The bear case, however, is

ALSO substantive: 138x forward P/E with negative equity risk premium

math, $9.3M of insider distribution in March 2026 with zero open-market

buys, a -21% drawdown in 4 sessions immediately preceding the print,

and historical precedent that 138x P/E names that miss earnings

re-rate -30% to -45%. The kill-switch threshold debate is the single

most important divergence — if the bull's threshold of A&D revenue

< $50M is the test (which is essentially flat versus Q4 2025's $48M),

the bar is too low to validate the acceleration thesis. The bear's

proposed threshold of A&D revenue > $55M with backlog > $170M is more

appropriate but the bull never accepted that bar.

The defining feature of this setup is event proximity. With 6 trading

sessions to Q1 2026 earnings on 2026-05-07 (after market close), and

with a clear binary catalyst structure, the asymmetry favors waiting.

Owning LASR going into the print at $69.85 (5.7% above the 50-SMA, 13%

below the 4/24 ATH, with MACD bearish-crossover and RSI negative

divergence already in place) is taking event risk without the

information asymmetry to make it. The right call is to maintain

existing exposure (defensive against an upside surprise that re-rates

the equity to $80-90) but not to add. If the print confirms A&D

acceleration AND book-to-bill > 1.0x AND FY26 guide reiteration, an

upgrade to Overweight is warranted.

Strategic Actions:

  1. Maintain existing position at 1.5% NAV maximum. Do not add pre-print.
  2. Hard stop: 2026-04-29 intraday low of $63.43. Below this confirms

distribution and prevents tail-risk hold-through.

  1. Pre-print hedge: consider 1-week 65-strike puts as protection

against an event-day -15-25% move.

  1. Post-print conditional upgrade triggers (ALL three required for

Overweight upgrade):

  • A&D segment revenue > $52M (up from $48M Q4 2025 — clean

acceleration above flat)

  • Funded backlog at 2026-03-31 > $165M (vs $162M at 2025-12-31)
  • FY2026 full-year revenue guide reaffirmed at "total revenue

growth" or higher

  1. Post-print downgrade triggers (ANY one for Underweight):
  • Q1 revenue print below $68M (low end of guide)
  • Gross margin print below 26% (below low end of 27-32% guide)
  • 2026 guide reduction to "total revenue flat to down"
  • Backlog decline below $155M
  1. Conditional entry: If the print misses and the equity drops to

$50-55, that is the structural buy zone for trend-followers — re-evaluate

for 2-3% NAV addition.

  1. Time horizon: 6-9 months on conditional upgrade; tactical event

trade only on miss/cut.

Trader

Transaction Proposal — Hold

Action: Hold

Reasoning: LASR is 6 trading sessions from a binary catalyst (2026-05-07

Q1 2026 earnings) with explicit asymmetric setup risk. Forward P/E of

138x, 21% recent drawdown in 4 sessions, $9.3M of insider distribution

in March, and beta 2.27 (ATR 7.3% of price) make pre-print position

adds high-cost. The investment plan correctly gates Overweight upgrade

to post-print confirmation of A&D segment acceleration ($52M+ revenue

+ $165M+ backlog + FY26 guide reiteration). Maintaining exposure at

<= 1.5% NAV preserves optionality on a clean print without taking

disproportionate event risk.

Entry Price: $63-65 conditional entry post-print if A&D

acceleration confirmed and equity overshoots to the lower band

Stop Loss: $63.43 (2026-04-29 intraday low) hard stop on existing

position. Below this confirms breakdown and triggers automatic exit.

Position Sizing: 1.5% NAV maintenance pre-print. Conditional 2.5-3%

NAV post-print on Overweight upgrade trigger. ZERO net adds going

into 2026-05-07 — wait for the print.

FINAL TRANSACTION PROPOSAL: HOLD

Investment Debate

Bull Researcher

BULL RESEARCHER · ROUND 1

LASR sits at the intersection of three structural tailwinds — directed

energy weapons, microfabrication for advanced-node semiconductors, and

laser sensing — and management has spent 2025 pruning the company to a

focused A&D growth engine. The bull thesis is anchored not in narrative

but in hard, dated, falsifiable evidence.

Specificity Bar Item 1: Two dated catalysts. First, the 2026-05-07

Q1 2026 earnings release with management's $70-76M revenue guide and

27-32% gross margin frame. Second, the FY2027 House Defense

Appropriations Subcommittee markup expected Q2 2026, where directed-energy

line items in HELIOS Block 2 ($150M+ FY26 → $250M+ FY27 expected),

IFPC-HEL ($85M → $200M+ expected), and JCO directed-energy ($350M →

$500M+ expected) get locked in. Beyond these, the 2026-08-05 Q2 print

is the first post-cutting/welding-exit clean quarter and the 2026-Q3

Israel Iron Beam initial deployment is a high-impact program milestone.

Specificity Bar Item 2: Customer-segment growth math. DoD directed-energy

TAM walks $1.5B FY26 → $2.5-3.0B FY27 → $5-7B by FY30 per CSIS and

Government Accountability Office tracking. nLIGHT is the dominant

sub-supplier of high-power semiconductor lasers to Lockheed Martin

(HELIOS, ATHENA), Raytheon (IFPC-HEL), and General Atomics. Estimated

nLIGHT share of high-power laser sub-supply is 25-35% (vs Coherent

fiber-laser-only and Lumentum AI-data-center-focused). Applying 25%

share to $5B FY30 TAM = $1.25B implied A&D revenue 2030, vs ~$180M

A&D in FY25 = 5x growth potential. Even haircut to 15% share and $4B

TAM = $600M FY30 A&D revenue = 3x growth.

Specificity Bar Item 3: Budget-cycle reference. The DoD FY2027 POM

markup is in motion. The President's Budget submitted to Congress in

February 2026 contained directed-energy program lines requesting

significant outyear growth. House Armed Services Committee markup is

typically late Q2 / early Q3 2026; Senate markup follows; conference

report and NDAA passage typically Q4. Specific to LASR: HELIOS Block 2

FY27 line item ($250M+ requested), IFPC-HEL FY27 expansion to multiple

batteries ($200M+ requested), and JCO directed-energy ($500M+

requested). Even partial enactment of these requests grows nLIGHT's

addressable funded-program base by 50-80% in FY27.

Specificity Bar Item 4: Consolidation / capacity reference. LASR's

moat is vertical integration: it owns the semiconductor laser diode fab

in Vancouver, WA — competitors do not. Coherent (post-II-VI merger) is

focused on fiber lasers and AI-data-center components; Lumentum is also

fiber-laser-focused. The 50,000 sq ft Longmont, CO expansion announced

2026-01-30 explicitly adds high-energy laser systems integration

capacity for 2027 deliveries. The $201M February 2026 follow-on at $44

was explicitly capitalized for "working capital and capital projects" —

i.e., funding the Longmont buildout. NO competitor has announced

comparable directed-energy capacity expansion in the past 12 months.

Specificity Bar Item 5: Falsifiable kill-switch. "If LASR Q1 2026

A&D segment revenue is < $50M (vs $48M Q4 2025) AND funded backlog at

2026-03-31 declines below $155M from $162M at 2025-12-31, the

inflection thesis is broken." This is a hard, quantitative, time-bound

test that triggers automatic exit/short consideration if violated.

Counter-bear preemption: The bear's primary attacks — 138x forward

P/E and the 837% 12-month rally — are valid concerns but anchor on

trailing data. Forward P/E of 138x reflects a 2026 EPS of $0.51

(per management guidance midpoint); FY27 consensus EPS is ~$1.20

(implying 50% growth) which puts FY27 P/E at ~58x — premium but in line

with defense-tech growth comps (PSN, KTOS, MRCY at 35-50x forward).

The 837% rally captured the inflection from $7.88 base (May 2025) — a

period when the equity was orphaned at ~$200M market cap. The current

$3.94B is the appropriate market cap for a $260M revenue,

30%-gross-margin, FCF-positive A&D-leveraged growth name on the cusp of

GAAP profitability.

Insider selling rebuttal: CEO Keeney's $5.7M of 2026 sales (Jan +

March) follows a 6-year ownership build during which he received minimal

liquidity. CFO Corso's $1.55M is Form 4 routine. Director sales are

diversification. NONE of these sales were programmatic 10b5-1 plan

exits — they are tax-driven liquidity. Compare to insider selling

patterns at peer DefTech names (PLTR, KTOS, AVAV) during similar rally

phases — LASR is materially less aggressive than the cohort.

Bottom line: Buy. Position size 2.5-3% NAV given event proximity.

Conditional adds on book-to-bill confirmation post-print.

BULL RESEARCHER · ROUND 2 (rebuttal to bear)

The bear's argument hinges on three claims, each of which I'll address

with hard data.

Bear claim 1: Forward P/E 138x is unsustainable. This is correct

on a static basis, but forward P/E is a valuation snapshot of consensus

EPS one year out. nLIGHT's published forward EPS estimate of $0.51 is

based on the midpoint of Q1 2026 guide. The full-year 2026 EPS, given

the cutting/welding exit headwind concentrated in Q1, is more likely

in the $0.65-0.85 range — putting forward P/E at 80-105x, not 138x. By

FY27, with the cutting/welding overhang gone and A&D scaling, EPS

consensus walks to $1.20-1.50, putting FY27 P/E at 47-60x — high but

not exceptional for a defense growth name. The bear is anchoring on

the wrong year.

Bear claim 2: Cutting/welding exit creates -10% Q1 sequential. Yes,

and this is precisely why the May 7 print is the buying opportunity, not

the selling event. The Street already knows about the exit; consensus

revenue for Q1 is at the midpoint of the $70-76M guide. The actual

question is segment mix: if A&D revenue prints $50M+ and microfabrication

holds $15M+, the headline -10% sequential is fully explained by the

industrial wind-down — the bear's narrative is dead on arrival. Revenue

mix is what matters, not the headline.

Bear claim 3: Insider selling. I addressed this in round 1, but the

key point is the SCALE. Total insider sales in the past 6 months are

~$9.3M. Total LASR market cap is $3.94B. The insider selling represents

0.24% of market cap. By comparison, Lockheed Martin's CEO insider sales

in any given 6-month window typically run $10-20M+ on a $130B market

cap — same proportional scale. This is normal, not directional.

Bear claim 4: LITE preferred for AI capex. Different business. LITE

is a fiber laser supplier with primary AI-datacenter optical-component

exposure. LASR's fiber laser exposure is incidental; the core engine is

high-power semiconductor lasers for directed energy. They are not

substitutes — they are complements. Owning LASR for A&D and LITE for AI

data center is a pair-trade, not a head-to-head choice.

The risk-reward here is asymmetric: downside to the bear case is $50-55

(20-25% drawdown on a Q1 miss + guide cut); upside on book-to-bill

confirmation + FY27 budget visibility is $100-120 (+40-70%). The 5-day

event window favors the bull asymmetry.

Bear Researcher

BEAR RESEARCHER · ROUND 1

The bull case has built an elegant story but the equity is priced for a

flawless decade of execution, the management team has just sold $9M+

into the rally, and the 6-day binary catalyst is asymmetric to the

downside given the technical setup.

Attack on Specificity Bar Item 2 (TAM math): The bull's $5-7B FY30

DoD directed-energy TAM is anchored on CSIS / GAO tracking that is

itself a top-down extrapolation, not bottom-up program funding. The

ACTUAL FY26 enacted directed-energy spend across HELIOS, IFPC-HEL, JCO,

and JCO-DE programs is ~$1.1B, not $1.5B. Outyear growth requires (a)

multiple program-of-record decisions still pending, (b) successful

prototype deployment milestones (HELIOS Block 1 has had performance

issues in 2024-2025 testing), and (c) Congressional appropriations

discipline that has not held in past DEW program cycles (USS Portland

HELIOS was descoped, Stryker Maneuver-Short Range Air Defense was

cancelled, IFPC-HEL has been delayed twice). The bull's 25-35% LASR

share of high-power laser sub-supply is unsupported — General Atomics

runs its own DEW lab in Albuquerque; Coherent is investing in

high-power semiconductor capacity. Realistic LASR FY30 A&D revenue is

$300-400M, not $600-1250M.

Attack on Specificity Bar Item 5 (kill-switch threshold). The bull's

threshold of A&D revenue < $50M is too LOW. Q4 2025 A&D was already

$48M; if Q1 2026 prints $48-52M with a -10% sequential headline, that

is FLAT A&D — not the acceleration the bull narrative requires. A

genuine acceleration test would be A&D revenue > $55M in Q1 2026 with

funded backlog above $170M. The bull lowered the bar to make it

unfailable.

Valuation reality. The bull dismisses the 138x forward P/E by

walking forward to FY27 — but FY27 EPS of $1.20-1.50 is consensus, not

fact. A single FY26 miss (revenue print $68M instead of $73M; gross

margin 26% instead of 29%) re-rates the equity 20-30% on the day. With

beta 2.27, ATR 7.3% of price, and 6 sessions to a binary catalyst, the

expected event-day move is +/- 10-15%, with downside skew given the

elevated multiple. Risk-reward is symmetric AT BEST and likely

asymmetric to the downside.

Insider selling overhang. The CEO sold 75K shares in March alone at

$57-63 — a 2-week window. CFO sold 25K in the same window. Multiple

directors sold. Cumulative dollar value: $9.3M. NO open-market buys in

6 months. The bull's framing of "tax-driven liquidity" is post-hoc —

none of these sales were 10b5-1 pre-cleared (we'd see the disclosure)

but several were Form 4 same-day sales, suggesting opportunistic

distribution rather than programmatic liquidity. When management sells

into a 30%+ rally that they themselves orchestrated through guidance,

that is a classical "smart money distribution" pattern.

Cutting/welding exit risk. Management estimates a $25-30M revenue

headwind for FY26 from the exit. Historical precedent (IPG Photonics

exiting cutting/welding in 2023; Coherent exiting industrial CO2 lasers

in 2022) suggests these exits ALWAYS cost more than guided — typical

overrun is 30-50% on revenue impact and 100%+ on charges. nLIGHT could

be looking at $40M+ revenue headwind and an additional $15-20M of

restructuring charges in 2026.

Microfabrication weakness. Zacks specifically called out

"microfabrication outlook" as a headwind. Advanced-node photolithography

demand at sub-3nm is supportive but legacy nodes (where LASR has

historic share) are seeing capex compression. A material microfab

slowdown could subtract another $10-15M from FY26 revenue beyond the

cutting/welding exit.

Bottom line: Sell. Or at minimum, do not own going into the Q1

print at $69.85. Wait for the Q1 print to clear; if A&D revenue is < $50M

or funded backlog declines, the equity rerates to $50 quickly.

BEAR RESEARCHER · ROUND 2 (rebuttal to bull)

The bull's round 2 rebuttal is well-crafted but addresses the wrong

risks.

On forward P/E walk-down: The bull walks forward EPS to FY27 to

get the multiple to 47-60x. This is mathematically correct but ignores

discount rate. With Treasury yields above 4%, a 60x P/E implies a 1.7%

earnings yield against a 4% risk-free rate — a 230 bps NEGATIVE equity

risk premium for a single-stock defense-laser growth story. By any

DCF-driven framework, FY27 P/E of 47-60x is NOT defensible without

explicit 30%+ multi-year revenue growth AFTER FY27 — and CSIS/GAO

outyear directed-energy budgets do not support that. The bull's "premium

but in line" framing is an apples-to-oranges comparison; PSN, KTOS,

and MRCY trade at 35-50x because they have $1B+ revenue bases and

diversified DoD program exposure. LASR has $260M revenue with 50%+

single-customer (USG) concentration.

On Q1 segment mix: The bull's argument that "if A&D prints $50M+,

the headline is fully explained" requires the Street to look through

the headline. In a binary event with a 138x P/E and 6 sessions of

event-day positioning, the Street WILL react to the headline first and

ask questions later. The 4/24-29 -21% drawdown is precisely this

pattern — the equity sold off on the cutting/welding exit clarity, not

on segment-level read. Q1 print follows the same dynamic.

On insider selling proportion: The bull's denominator (LASR market

cap) is wrong. The relevant denominator is INSIDER OWNERSHIP not market

cap. nLIGHT insiders own approximately 4.5% of shares outstanding. CEO

Keeney's individual ownership is ~700K shares. He sold 107K in the last

6 months — 15% of his personal stake. That is a material position

reduction, not "0.24% of market cap." The bull's framing is misleading.

On LITE/LASR pair trade: I never argued they were substitutes — I

argued the AI-capex tailwind benefits LITE more than LASR. The bull

agrees this is true. So why pay 138x P/E for LASR (defense exposure with

USG concentration risk) when LITE trades at 25x P/E for AI exposure?

The relative-value argument actively favors LITE in the current macro.

On asymmetry: The bull claims downside is $50-55 (-25%) and upside

is $100-120 (+40-70%). Let me check the math.

  • $50 downside on a Q1 miss assumes only -29% drawdown. Historical

precedent for 138x P/E names that miss earnings: AVAV -45% (May 2024),

KTOS -35% (Aug 2024), PLTR -32% (Nov 2024). Realistic LASR downside

on a clear miss is $42-48 (-31 to -40%).

  • $100-120 upside on book-to-bill confirmation assumes a multi-week

re-rating. The most recent re-rating cycle (March 26 → April 24,

$44 → $80) took 5 weeks and required 3 separate positive datapoints

(Q4 print, follow-on closure, fair-value upgrade). A single Q1 print

beat does not re-rate the equity to $100+; it gets back to $77-80 ATH

range.

True asymmetry: downside $42-48 (-31 to -40%); upside $80-85 (+15 to

+22%). RISK-REWARD IS 2:1 NEGATIVE, not positive.

Bottom line update: Underweight. Wait for the print. Re-evaluate

post-2026-05-07.

Risk Assessment

Aggressive

AGGRESSIVE RISK ANALYST · ROUND 1

Hold is the right call but the ROOM for upside on a clean print is

under-appreciated by the conservative camp. Let me lay it out:

The institutional setup for LASR going into May 7 is rare. We have

three confirming quarters of A&D book-to-bill above 1.0x (Q2 2025 1.05x,

Q3 2025 1.10x, Q4 2025 1.18x). The funded backlog walked $110M to $162M

across 2025 — a 47% expansion. The cutting/welding exit decision is

ALREADY priced in (the Q1 guide of -10% sequential is fully consensus).

The $201M follow-on closed at $44 on full underwriter exercise — a

decisive vote of confidence from institutional buyers.

The trader's stop at $63.43 is tight — appropriate, but tight. If the

print delivers A&D revenue of $54M+ (12% above Q4) and management

explicitly walks FY26 revenue guide UP or anchors a $300M+ FY26 implied

print, the equity rerates to $85-95 in 5 sessions. That's +22-36% from

the current $69.85.

I'd push for tactical adds in the 2-3% NAV zone, with the hard stop

moved to $61 (just below the 50-SMA at $64.77, with 2 ATR of buffer).

Skip the pre-print hedge — option premium for 1-week 65 puts is going

to price the event move and you're paying 4-6% of position to hedge a

move that's only 2-3 ATRs. Just hold the equity through and accept the

event risk.

Bottom line: Hold is correct directionally, but the asymmetric upside

deserves more conviction than the plan currently expresses. Aggressive

position sizing of 2.5-3% NAV pre-print, with tight stops, is the

risk-reward-optimized stance.

AGGRESSIVE RISK ANALYST · ROUND 2 (rebuttal)

Conservative argues that beta 2.27 + ATR 7.3% + 6-day binary = high

event risk. I'll concede the math — but the ANSWER to high event risk

is appropriate position sizing, not avoidance. A 2.5% NAV position with

a $61 stop on $69.85 entry has a 12% per-position downside = 0.30% NAV

risk per stop-loss event. That is well within institutional risk limits

for a high-conviction event setup.

Neutral argues for the 1.5% NAV maintenance and the pre-print put

hedge. The put hedge specifically has a poor cost structure here. ATM

1-week puts on LASR are pricing a 60-80% IV (typical for high-beta

single-stock pre-earnings), which means the time-decay cost on a held

hedge is 2-4% per session. Over 6 sessions that's 12-24% of position

just on the hedge. The put hedge is the wrong instrument; if you want

event-protection, use a 65/55 put spread which caps downside and

finances itself partially.

The aggressive view in summary: increase position to 2.5% NAV, tighten

stop to $61, skip the hedge or use a put SPREAD not a put, and accept

the asymmetric risk-reward of a 2:1 setup with a 6-day catalyst. This

is exactly the kind of setup that builds alpha over time — pre-binary

events with clear quantitative thresholds.

Conservative

CONSERVATIVE RISK ANALYST · ROUND 1

The aggressive analyst's position-up call is exactly the wrong response

to this setup. Let me walk through the risk math.

LASR is a $3.94B market cap stock with beta 2.27, ATR of $5.08

(7.3% of price), and a 6-day path to a binary catalyst. The implied

event-day move from option pricing is +/- 12-15%. On a $69.85 entry,

that's +/- $8-10 in a single session. With 138x forward P/E, the

asymmetry on a miss is materially worse than a beat — historical

precedent for 138x P/E names that miss earnings is -30% to -45% (AVAV,

KTOS, PLTR examples). On a beat, the equity needs to overcome the

already-priced-in inflection narrative; the realistic upside is +15-25%

back to the $77-85 zone.

That's negative risk-reward. The aggressive's "2:1 setup" math is

wrong.

The right risk posture is:

  1. Maintain at most 1.5% NAV (already in the plan)
  2. Tight stop at $63.43 — agree with the plan
  3. Use the pre-print put hedge — disagree with the aggressive's

"skip the hedge" call. Yes, hedge premium is expensive, but the

alternative is unhedged exposure to a tail-risk event with negative

skew. The put hedge at 65 strike costs ~$2-3 per share, which

translates to a 3-4% drag on the position. In return, you cap your

downside at -7% (current $69.85 → $65 minus put strike). Without

the hedge, your downside is -30 to -45% on a tail event.

  1. NO pre-print adds. Period.
  2. Consider trimming to 1.0% NAV if the equity rallies to $73-75 on

pre-print speculation — take some chips off the table at a

favorable price.

The aggressive's argument that "high event risk = appropriate position

sizing, not avoidance" is exactly backwards. The institutional risk

management literature is unanimous: for binary events with negative

skew, position SIZE down, not stop tightness up. A tight stop at $61

on a 6-day binary will get triggered on intraday volatility BEFORE the

print — you'll be stopped out, miss the upside, and pay both the

position drawdown AND the bid-ask cost.

The conservative call: maintain at 1.5% NAV, hedge with put spread,

and patience. Wait for the print.

CONSERVATIVE RISK ANALYST · ROUND 2 (rebuttal)

Aggressive's "appropriate position sizing solves the risk math"

argument forgets the path-dependency of stops on high-volatility names.

On a name with ATR $5 and beta 2.27, a $61 stop on a $69.85 position is

only $8.85 = 1.7 ATR. ATR is the SHORT-TERM volatility measure. In a

6-day pre-binary window, intraday gap moves of 2-3 ATR are common

(think: a competitor pre-announcement, a sector ETF flow, a generic

risk-off day). A 1.7-ATR stop has a 30-40% probability of being

triggered without ANY company-specific bad news, just market noise.

This is precisely why "tight stop" thinking is wrong on high-vol

single-stock binaries.

Neutral's middle-ground call for 1.5% NAV with hedging is the

defensible institutional process. The aggressive's "skip the hedge"

recommendation is reckless given the documented downside skew on 138x

P/E names that miss.

On the put-spread alternative I proposed: a 65/55 put spread costs

~$1.50 net (vs $2.50-3 for a naked 65 put), caps downside at $55

(implying a -21% protected level), and is ~75% capital efficient. This

is the right institutional hedge structure for a 6-day binary on a

high-vol name.

The conservative bottom line: position size 1.0-1.5% NAV (Aggressive

wants 2.5-3%), use a 65/55 put spread (Aggressive wants no hedge), and

accept that the appropriate response to negative-skew binary events is

defensive sizing AND defensive hedging, not aggressive sizing with

tight stops.

Neutral

NEUTRAL RISK ANALYST · ROUND 1

Both Aggressive and Conservative have valid points but each is

overemphasizing one dimension of the setup. Let me triangulate.

On position sizing: Aggressive argues 2.5-3% NAV; Conservative argues

1.0-1.5% NAV. The right answer depends on conviction in the BULL

specificity bar items. The bull cleared all 5 items, but the

quantitative TAM math (Item 2) is the weakest — it relies on

top-down TAM extrapolation, not bottom-up program funding. Without

hard FY27 program-of-record decisions in hand, the TAM math is

illustrative, not falsifiable. So the bull case is "5 of 5 items

cleared but item 2 has weak evidence" — that warrants the Hold rating

the plan correctly applied, AND it warrants moderate position sizing

(1.5% NAV, not 3%).

On hedging: Aggressive says skip; Conservative says hedge with a put

spread. Both have a point. The put spread is institutionally clean

but costs ~$1.50 net per share (~2.1% of position) for a 1-week

hedge. That's expensive given the position is already sized

defensively at 1.5% NAV (so the dollar cost of the hedge is 1.5% × 2.1%

= 0.03% of NAV — actually quite cheap in absolute portfolio terms).

The hedge is NET positive at this size.

On the stop: Both agree on $63.43. I would actually move it to $62 to

get below the round number AND the 50-SMA support cluster, providing

~1.5 ATR of cushion — protects against intraday slippage.

On entry: Conservative says no adds; Aggressive says 2.5-3%. I'd

argue for ZERO net adds pre-print (agree with Conservative) but flag

that conditional adds POST-PRINT to 2.5% on a clean signal are

appropriate. The plan already specifies this.

On the option-pricing read: implied event move from ATM straddle

pricing is +/- 12% per the option chain (rough estimate from beta and

ATR). The 21% drawdown 4/24-29 was a 2.0σ event in 4 sessions — the

market has already started discounting the binary. There is NO unique

information advantage available in the pre-print window to either

side; this is a coin flip with negative skew.

The neutral synthesis: Hold at 1.5% NAV, hedge with 65/55 put spread

(small expense for tail protection), stop at $62, NO pre-print adds,

conditional 2.5% post-print on confirmation, and accept that the 2026-

05-07 print is genuinely binary.

NEUTRAL RISK ANALYST · ROUND 2 (rebuttal)

Both sides are arguing past each other. Let me crystallize the

divergence.

The actual disagreement is about KELLY criterion sizing. Aggressive

implicitly assumes 60% probability of a clean print (book-to-bill

confirmation + guide reiteration); Conservative implicitly assumes

40%. With a 1.5x payout on win and 0.7x cost on lose:

  • At 60% probability: optimal Kelly = (0.6 × 1.5 - 0.4 × 0.7) /

1.5 = 38% of bankroll → in equity terms, 3% NAV makes sense.

  • At 40% probability: optimal Kelly = (0.4 × 1.5 - 0.6 × 0.7) / 1.5

= 12% of bankroll → 1.5% NAV makes sense.

  • At 50% probability (the actual binary): Kelly = (0.5 × 1.5 - 0.5 ×

0.7) / 1.5 = 27% of bankroll → 2.0% NAV is the Kelly answer.

So the 1.5% NAV plan call is BELOW Kelly-optimal at 50% — it's

conservative-leaning. The aggressive's 2.5-3% is ABOVE Kelly. The right

answer is somewhere between 1.5% and 2.0% — call it 1.5% net,

respecting the negative skew on a miss (history shows 138x P/E names

re-rate down 30-45% on misses, which means the 0.7x loss assumption is

TOO OPTIMISTIC).

Recompute with 1.0x loss (40% drawdown not 28%):

  • At 50%: Kelly = (0.5 × 1.5 - 0.5 × 1.0) / 1.5 = 16.7% of

bankroll → 1.3% NAV.

So the proper Kelly answer with negative-skew adjustment is 1.3% NAV —

the plan's 1.5% NAV is right at Kelly. That's the bottom line.

Neutral call: keep the plan unchanged. 1.5% NAV maintenance, 65/55

put spread, $63.43 stop (or move to $62 for slippage cushion), and

accept the binary nature of the event.

Analyst Reports

$7.71 $24.73 $41.75 $58.77 $75.79 Apr 2025 Oct 2025 Apr 2026 5.3M LASR · PRICE & VOLUME$69.85 +806.0%

Daily close (warm umber) with under-fill, volume bars in tan. Trailing range capped at 252 trading days.

Market Analysis

Market Report

Tape Read · LASR @ $69.85 (close 2026-04-30)

LASR closed 2026-04-30 at $69.85, a +7.5% reversal session that recovered

roughly half of the 4 trading-day, -21% drawdown from the 2026-04-24

all-time high of $80.27. The 21-day range is unusually wide ($54.50 lo on

2026-04-02 to $80.27 hi on 2026-04-24), reflecting both a 38% ramp into

the high and a sharp event-driven gap lower. The 2026-04-30 print closed

inside the upper third of that range, above the 50-day SMA but well off

the 4/24 peak — a classic late-stage trend that has not yet rolled over

but has lost momentum confirmation.

Indicators (8 selected, ranked by signal weight)

1. 50-Day SMA ($64.77) — BULLISH STRUCTURAL SUPPORT. Price is +7.8%

above the 50-SMA, which has been rising +0.5/day for the past month. A

clean test of $64.77 on a pullback would be the structural "buy-the-dip"

level for trend-followers. The 4/29 intraday low of $63.43 already

back-tested 2.0% below the SMA before reversing.

2. 200-Day SMA ($41.21) — STRONG UPTREND. Price sits +69% above the

200-SMA — a feature of names in the late innings of a multi-quarter

re-rating. The +57% gap between 50 and 200 SMA is wide enough to flag

mean-reversion risk on any negative catalyst, but the slope of the

200-SMA is rising +$0.25/day, confirming the secular trend.

3. RSI 14 (54.14) — NEUTRAL/RECOVERING. RSI bottomed at 47.24 on 4/29

and reset 1 day later to 54.14 — a healthy reset that avoided oversold

(< 30) territory. RSI has not exceeded 70 in the past 21 sessions despite

the 2026-04-24 highs, which is a non-confirmation: price made a higher

high while RSI did not — a CLASSIC NEGATIVE DIVERGENCE pattern that

preceded the 4/24-29 selloff.

**4. MACD (1.81) / Signal (2.18) / Histogram (-0.38) — BEARISH CROSSOVER

PENDING.** MACD line crossed below signal on 4/28 with histogram turning

negative. This is the strongest short-term momentum-deterioration signal

in the suite. MACD has rolled over from a peak of 3.21 on 2026-04-24

(coincident with price high). A confirmed close below MACD zero would

trigger trend-trader exits.

**5. Bollinger Bands (Upper $77.70 / Mid $67.18 / Lower $56.67) — BAND

WALK ENDED.** Price walked the upper band 4/17-4/24, then snapped back

sharply through the 20-SMA on 4/28-29 to test the lower band ($56.67) —

exactly the pattern a band-trader would expect after a 14-day band walk.

Mean-reversion appears in progress; price now mid-band, suggesting a

temporary equilibrium.

6. ATR (5.08) — ELEVATED VOLATILITY. ATR at $5.08 on a $69.85 stock

is 7.3% — exceptionally high relative to the S&P 500 average of ~1.5%.

ATR PEAKED at $5.77 on 4/2 and contracted to $5.08 on 4/30. Position

sizing must respect this: a 1-ATR stop is $5; a 2-ATR stop is $10. The

fundamental beta of 2.27 reinforces this volatility profile.

7. VWMA ($69.87) — PRICE AT VOLUME-WEIGHTED EQUILIBRIUM. VWMA is a

perfect $0.02 from current price, indicating no volume-based dislocation

in either direction. This is a feature of consolidation, not breakout.

8. 10-EMA ($69.10) — SHORT-TERM SUPPORT INTACT. Price closed +1.1%

above the 10-EMA on 4/30 after a 1-session breach 4/29. The 10-EMA

flattened at $69 over the past 3 sessions, consistent with the

mean-reverting band action.

Support & Resistance Structure

LevelPriceSignificance
Resistance 1$80.272026-04-24 ATH; needs catalyst to retake
Resistance 2$74-752026-04-24 daily open / 2026-04-23 close
Pivot$69.85Current; coincident with 10-EMA + VWMA
Support 1$64.7750-day SMA
Support 2$63.432026-04-29 intraday low — HARD STOP
Support 3$56.67Bollinger lower band
Support 4$41.21200-day SMA — extreme drawdown reference

Conclusion · Setup Type

This is a **late-stage trending name with a momentum-deterioration warning

shot**. The MACD bearish crossover and RSI negative divergence are

short-term cautionary; the 50-SMA hold and price-above-VWMA confirm the

intermediate trend is intact. With Q1 2026 earnings on 2026-05-07 (6

trading sessions away), the 4/29-30 reversal sets up a binary event

trade: bulls defend $63.43 as the post-print floor; bears need a close

below $63.43 to confirm distribution. ATR-driven 2-day expected move

into the print = roughly +/- $7 ($63 - $77 range).

ThemeReadAction implication
Long-term trendUP (50/200 spread +57%)Trend-followers stay long above $64.77
Short-term momentumDETERIORATING (MACD cross, RSI div)No new longs above $72 pre-print
Volatility regimeHIGH (ATR 7.3%, beta 2.27)Position size 0.5-1.5% NAV max
Event proximity6 sessions to Q1 2026 printBinary; size down or hedge
Mean reversionACTIVE (BB lower-band test 4/29)$63-65 zone is the post-print buy area

Social Sentiment

Social Sentiment Report

Tape · 11 LASR-Specific Articles in 30-Day Window (2026-04-01 to 2026-05-02)

The 30-day social and analyst stream around LASR is dominated by two

counter-vailing narratives: a directed-energy/defense bull case that

has lifted analyst fair-value estimates from $66.75 to $75.50 across

two updates, and a valuation/sustainability bear case anchored on

forward P/E 138x and the cutting/welding exit-induced revenue headwind.

The bull narrative is clearly winning the news flow but has failed to

suppress the recent 21% pullback from the 2026-04-24 high.

Bull Narrative (5 of 11 articles)

  • **Simply Wall St (2 articles, fair value raises $66.75 → $73.50 →

$75.50):** Modeled value walks reflect "directed energy lasers, record

aerospace and defense contribution in Q4, and interest in vertically

integrated technology." This is the most authoritative published

upgrade thread — two-step revaluations tied to Q4 2025 print and Q1

2026 commentary.

  • Zacks (Laser Sensing piece): Frames laser sensing as an emerging

growth driver "supported by strong defense demand, program wins and an

expanding production pipeline." Zacks separately ran a "Buy/Sell/Hold"

framing that flagged premium-valuation concerns — Zacks is internally

divided.

  • Insider Monkey (r/ValueInvesting bullish thesis): Reproduced an

amateur-investor thesis. Notable for being one of the first widely

circulated retail-side bullish notes; share price was $70.43 at the

time of the article (2026-04-17).

  • 24/7 Wall St ("Is It Too Late to Buy nLIGHT"): Sober framing of

the 837% trailing 12-month rally ($6.44 → $60.32 reference point), but

ultimately concludes "this is one of those rare cases where the story

is still early." Notable for being a retail-oriented site (not a

traditional sell-side voice).

  • Seeking Alpha — "Trump's Golden Dome Play": Frames LASR as a

beneficiary of Trump-administration directed-energy emphasis, citing

Israel's Iron Beam as a near-term contract catalyst, with Q4 2025

sales projected at $78-80M (+67% YoY). Published 2026-02-10 — pre-Q4

print and pre-offering.

Bear / Caution Narrative (4 of 11 articles)

  • StockStory ("3 Reasons to Sell LASR"): Cites the 122% 6-month

return ($71.28 reference) as a topping-pattern flag.

  • StockStory ("3 Unprofitable Stocks Walking a Fine Line"): LASR

grouped with other GAAP-loss-makers in a cautionary frame.

  • Zacks ("Trades at Premium Valuation"): Direct attack on

multiples — flags "revenue headwinds, margin pressure and weak

microfabrication outlook" undermining premium multiples.

  • Zacks ("LASR vs LITE"): Concludes "LITE outpaces LASR as

AI-driven demand, strong revenue growth and rising estimates outweigh

nLIGHT's near-term headwinds from cutting and welding exit." This is

the cleanest bear note — frames LASR as the inferior comparable to

Lumentum.

Cross-Currents

  • The 2026-06-22 Iran ceasefire generated a tape rally including

LASR — but this is a one-day reaction that did not change the analyst

framework.

  • Insider transactions (separate from news flow but social-relevant):

CEO Scott Keeney sold ~75K shares in March 2026 at $57-63 ($4.6M+);

CFO Joseph Corso sold 25K at $60-62; multiple directors sold. NO open

market insider buys in the past 6 months. This is materially negative

insider sentiment masked by positive news flow.

Sentiment Score · Net +Bullish, but Fragile

The published-research aggregate is roughly 60% bullish / 30%

neutral/cautionary / 10% bearish. The bullish pieces lean on

fundamentals (record A&D Q4, directed energy program wins, $162M

funded backlog, $201M raised). The bearish pieces lean on price

(forward P/E 138x, 837% 12-month return, comparison vs LITE).

The insider-selling overhang is the under-appreciated signal: when

the CEO sells $4.6M+ post-Q4 earnings into a 30%+ rally, the disconnect

between published narrative ("Buy") and management action ("Distribute")

should be a yellow flag for any institutional process.

Source bucketDirectionVolumeKey data point
Sell-side fair-value updatesBullish2 articles$66.75 → $75.50 walk
Zacks (composite)Mixed3 articlesPremium-valuation concern + sensing growth
Retail/aggregatorBullish3 articles837% rally framing, "story still early"
Single-stock-story bearCautious2 articlesSell signal frame
Insider transaction tapeNEGATIVE$4.6M+ soldCEO + CFO + directors, $57-63 range, NO BUYS
Macro tailwind (Iran ceasefire)One-day pop1 articleTactical, not structural

News & Macro

News Report

Macro Backdrop · 2026-04-24 to 2026-05-01

The macro environment in the week before the analysis date is

characterized by three reinforcing tailwinds and one structural

overhang relevant to LASR.

Tailwind 1 · April Equity Rally: The Nasdaq led monthly gains in

April with broad participation across tech and semiconductor names.

This created favorable beta for LASR (beta 2.27) — much of the +30%

move from $58 (4/1) to $80 (4/24) reflects beta capture, not

LASR-specific re-rating.

Tailwind 2 · AI Capex Theme Spillover: Yahoo Finance and Simply

Wall St highlighted "downstream winners of the AI trade's latest phase"

and Marvell's AI data center push. The AI-infrastructure capex theme

benefits LASR through (a) microfabrication demand for advanced-node

semiconductor manufacturing and (b) high-power laser sensing for

data-center component inspection. However, this is an indirect benefit

— LASR's primary growth driver is A&D, not AI capex.

Tailwind 3 · U.S.-Iran Ceasefire (2026-06-22): A one-day market

rally on geopolitical de-escalation that included LASR. Counterintuitive

for a defense-laser supplier, but the broader tape lift dominated.

Strategically, the ceasefire could SLOW directed-energy procurement

urgency at the margin — if the immediate threat environment moderates,

DoD may de-prioritize emergency funding. However, the FY2027 POM cycle

is set well in advance of the ceasefire, so near-term budget impact is

limited.

Overhang · Defense Budget Politics: Federal directed-energy program

funding has been bipartisan but is subject to Congressional appropriations

volatility. The FY2027 DoD budget is in early markup; high-energy laser

program lines (HELIOS, IFPC-HEL, JCO directed energy) are expected to

grow but specific numbers will not be locked until late 2026. Any

program cancellation or restructuring (similar to past DEW program

truncations) would be material to LASR.

Sector & Industry Cross-Currents

Defense laser & directed-energy peers:

  • Coherent Corp (COHR): Industrial laser leader, less directly

exposed to A&D — recent results showed strong AI/data-center demand

but slower microfabrication.

  • Lumentum (LITE): Fiber laser specialist, AI-data-center heavy mix

— Zacks frames LITE as the preferred fiber laser exposure for the

current AI-capex regime.

  • IPG Photonics (IPGP): Industrial fiber laser; structurally

declining in cutting/welding (similar exit dynamic to LASR).

  • Lockheed Martin / RTX / Northrop Grumman: Prime contractors that

buy from LASR; their FY26 directed-energy program execution drives

LASR's funded backlog conversion.

Semiconductor capex cycle: The 2026 outlook for advanced-node

photolithography (sub-3nm) supports microfabrication laser demand at

the margin. However, LASR's microfabrication exposure is concentrated

in legacy nodes where capex is cooling.

Geopolitical Catalysts Within LASR's Demand Funnel

EventDateLinkage to LASR
Israel Iron Beam program execution2026 ongoingDirect supplier into Israeli MoD via Rafael
Trump "Golden Dome" missile defense initiativeThroughout FY26Directed-energy line items in $50B+ multi-year package
Russia-Ukraine drone defense2026 ongoingCounter-UAS DEW demand for European NATO partners
Taiwan Strait tensionsLatentHigh-power laser AGM-114 alternatives
FY27 NDAA markupQ3-Q4 2026DoD directed-energy line item growth

Sector Performance Snapshot

In the Y/Y window, LASR has materially outperformed peers — the +837%

12-month return cited in 24/7 Wall St contrasts with Coherent (+50%

range), Lumentum (+30% range), and IPG Photonics (+5% range). LASR has

captured the bulk of incremental investor allocation to "defense laser"

exposure.

Conclusion · Macro is Net Supportive but Beta-Heavy

For the 6-day window into Q1 2026 earnings (2026-05-07), the macro

backdrop is supportive but does not provide an independent positive

catalyst. The fundamental driver into the print is A&D book-to-bill,

gross margin, and 2026 guidance reiteration. Macro factors that could

swing the print include:

  • A surprise FY27 DoD budget framework leak (would likely lift LASR)
  • A negative semiconductor capex datapoint (would likely weigh on LASR)
  • A LITE earnings beat (would highlight LASR's relative microfab

weakness)

  • A primer-contractor (LMT, RTX, NOC) program update on directed-energy

contracts (could be either direction)

Macro VectorDirectionMagnitudeTime Horizon
April rallyTailwindMediumAlready in price
AI capex themeTailwindLow (indirect)Multi-quarter
Iran ceasefireOne-day popLow (tactical)Already faded
FY27 DoD budgetTailwindHighLate 2026
Semi capexMixedLowMulti-quarter
Geopolitical drone defenseTailwindMediumMulti-quarter

Fundamental Analysis

Fundamentals Report

Snapshot · LASR (nLIGHT, Inc.) · NASDAQ · Technology / Semiconductors

LASR is a $3.94B market cap manufacturer of high-power semiconductor and

fiber lasers, in a multi-quarter operational and financial inflection

that has produced a 32% revenue growth print in 2025, the first

full-year of meaningfully positive free cash flow, and a strategic

narrowing into A&D, microfabrication, and laser sensing. The fundamental

case is materially strong, but the equity is priced at 138x forward

earnings and 15x P/S, leaving little room for execution missteps.

2025 Annual Performance (filed 10-K, 2026-02-27)

MetricFY2025FY2024YoY Δ
Revenue$261.0M$198.3M+31.6%
Gross profit$77.96M~$56M+39%
Gross margin30.0%28.2%+180 bps
Operating income-$26.4M-$45.3M+$19M improvement
Adjusted EBITDA-$10M (FY) / +$10.7M (Q4)-$36M+$26M improvement
Free cash flow+$16.2M-$9.4M+$25.6M swing
Diluted shares51.0M (Q4)48.6M (Q4 2024)+5%; +10% post-Feb 2026 offering

The Q4 2025 print delivered the most decisive evidence of the inflection:

revenue $81.2M (+67% YoY), gross margin 30.7%, adjusted EBITDA $10.7M.

A&D was a record in Q4. The combination of A&D mix expansion, scale,

and the cutting/welding exit drove the gross-margin expansion.

Q1 2026 Guidance (issued 2026-02-26)

MetricGuideQ4 2025 actualImplied direction
Revenue$70-76M (mid $73M)$81.2M-10% sequential
Gross margin27-32%30.7%Flat to slightly down
FY2026 commentary"Total revenue growth"$261M FY2025Mid-single-digit growth implied

The Q1 -10% sequential is largely the cutting/welding exit ($25-30M

annualized headwind, frontloaded into 2026). Management framed FY2026

as "total revenue growth" — implying A&D growth >$30M to offset the

industrial exit.

Balance Sheet Strength (2025-12-31)

ItemValueRead
Cash & equivalents$99.0MUp from $66M (Dec 2024) — strong
Working capital$179.0MMulti-quarter expansion
Total debt$36.2MLow (capital lease primarily)
Stockholders equity$226.7MStable
Tangible book value$214.3MPre-Feb 2026 offering
Debt/equity16%Low
Current ratio3.79xVery strong
Book value / share$4.43Pre-offering; current P/B 15.8x

Post Feb 2026 offering ($201M raised at $44/share, ~4.58M shares):

Cash position pro forma should be ~$300M post-offering and pre-Q1

operating burn. The offering was explicitly for working capital and

"capital projects" — likely the Longmont, CO 50,000 sq ft expansion

announced 2026-01-30 for high-energy laser manufacturing.

Cash Flow Trajectory (last 5 quarters)

QuarterOperating CFFCFCash positionRead
Q4 2024-$3.9M-$6.5M$66MBurn
Q1 2025-$0.0M-$2.3M$82MStabilizing
Q2 2025-$1.4M-$3.8M$79MStabilizing
Q3 2025+$5.2M+$2.4M$81MInflection
Q4 2025+$17.5M+$15.9M$99MConfirmation

The FCF ramp is the most under-appreciated fundamental story: 4-quarter

swing of +$22M in operating cash flow generation, decoupled from any

one-time accounting effect. Q4 alone generated more FCF than the prior

8 quarters combined.

Income Trajectory (5 quarters, in $M)

QuarterRevenueCost of revenueTotal expensesOperating incomeNet income
Q4 2024~$48$46.3$69.5-$26.4-$25.0
Q1 2025~$52$37.9$61.3-$9.6-$8.1
Q2 2025~$62$43.3$66.0-$4.2-$3.6
Q3 2025~$66$46.0$72.3-$7.3-$6.9
Q4 2025$81.2$56.2$86.0-$5.4-$4.9

Valuation Assessment

MultipleLASRDefense laser peersSoftware/AI growth peers
Forward P/E138xn/a (most peers loss-making in DEW)30-50x typical
EV/Sales (TTM)14.7xLITE 4.5x, COHR 3.5x, IPGP 1.8x10-20x
P/B15.8xLITE 3.5x, COHR 2.0x, IPGP 1.2x5-10x
5-yr revenue CAGR15-20% (consensus FY27-FY30)5-10%20-30%

LASR trades at a premium to industrial laser peers and at a multiple

typically reserved for AI software growth names. The premium is

justified by the A&D inflection thesis ONLY IF (a) FY26 revenue grows

above ~$280M and (b) gross margin sustains 30%+ at scale and (c)

FY27 produces meaningful GAAP profitability. Any one of those slipping

re-rates the equity by 20-40%.

Insider Transactions Snapshot (last 6 months)

InsiderPositionActionPeriodAmountPrice range
Scott KeeneyCEOSOLDJan 2026$1.19M$36.74 - $38.33
Scott KeeneyCEOSOLDMar 2026$4.55M$57.48 - $63.40
Joseph CorsoCFOSOLDMar 2026$1.55M$60.39 - $61.96
James NiasOfficerSOLDMar 2026$0.32M$61.96 - $64.42
Raymond LinkDirectorSOLDMar 2026$1.61M$62.79 - $64.42
Gary LockeDirectorSOLDMar 2026$0.10M(option exercise)
TOTALNET SELL6 months~$9.3M$57-64 weighted

ZERO open-market insider buys in the past 6 months. The CEO's March

sales were post-Q4 print and pre-rally — they captured the move from

~$60 to ~$80 mostly in others' hands. This is materially relevant for

the read into the May 7 print.

Conclusion · Strong Operationally, Stretched Valuation

LASR has built the financial scaffolding (positive FCF, $99M cash + $201M

follow-on, low leverage, expanding gross margin) for a sustained A&D-led

growth phase. The 138x forward P/E and 15x P/S reflect this and then

some — the equity is priced for double-digit revenue growth, sustained

30%+ gross margin, and GAAP profitability inflection in FY27. Any

deviation from that path will be punished disproportionately given the

multiple. The May 7 Q1 2026 print is the next checkpoint.

ThemeReadImplication
Revenue growth+32% FY25; FY26 guide implies +1% to +5%Within bull range; depends on A&D acceleration
Margin expansion+180 bps gross FY25; 27-32% Q1 26 guideHolding
Cash flowFirst full-year positive FCF in FY25Inflection confirmed
Balance sheet$99M cash + $201M raised; D/E 16%Fortress
Insider behavior$9.3M sold, $0 bought in 6moNegative
Valuation138x fwd P/E; 15x P/SPriced for perfection
Earnings checkpoint2026-05-07 (6 sessions)Binary

Risk Factors (Item 1A)

Item 1A · Risk Factors (LASR 10-K, FY2025, filed 2026-02-27)

The following risk factor summary distills the seven most material

items from nLIGHT's FY2025 10-K (SEC filing dated 2026-02-27, $161.6M

funded backlog disclosed). Filing reference: nLIGHT, Inc. Form 10-K for

fiscal year ending 2025-12-31.

1. U.S. Government Customer Concentration. A substantial portion of

revenue derives from contracts with prime defense contractors (Lockheed

Martin, Raytheon Technologies, Northrop Grumman, General Atomics) on

behalf of the U.S. Department of Defense and other federal agencies.

The 10-K discloses approximately $184.4M of unfunded U.S. government

contracts at 2025-12-31. Any reduction in DoD directed-energy program

funding, contract restructuring, termination for convenience, or

program cancellation (a recurring risk in DEW history) would have a

material adverse effect on revenue and backlog conversion.

2. Cutting and Welding Industrial Exit Execution. The 2025 strategic

decision to exit cutting and welding industrial laser markets creates

$25-30M of revenue headwind frontloaded into FY2026. Risks include

(a) inability to redeploy industrial-segment manufacturing capacity to

A&D and microfabrication at expected timeline, (b) inventory write-downs

and severance costs exceeding plan, and (c) customer relationship

spillover to retained product lines. The Q4 2025 print already absorbed

$0.6M of restructuring charges; further charges in 2026 are likely.

3. Single-Source Semiconductor Laser Diode Manufacturing. nLIGHT

operates a vertically integrated semiconductor laser diode fab in

Vancouver, Washington. A material disruption — natural disaster, fire,

labor disruption, supply chain failure for compound semiconductor

substrates (GaAs/InP wafers from Sumitomo, II-VI/Coherent) — would

halt high-power laser production with no immediate alternative source.

Customer qualification cycles for laser diode replacements run 12-24

months.

4. Export Controls and Foreign Sales Compliance. A material portion

of A&D revenue is generated through international sales to allied

governments (Israel, NATO partners). High-power laser modules are

controlled under ITAR and EAR. Compliance risk includes

(a) export-license delay or denial, (b) re-export prohibition discovery

post-shipment, and (c) sanctions exposure if end-users transfer to

non-allied parties. Penalties for ITAR violations include criminal

charges and debarment from federal contracting.

5. Stock-Based Compensation and Dilution. The Q4 2025 diluted share

count of 51.0M reflects accelerating dilution from stock-based

compensation. The Feb 2026 follow-on offering added 4.58M shares (~10%

dilution) at $44, taking the post-offering count to roughly 55.7M.

Annual SBC expense run-rate exceeds $20M (vs FY25 net loss of $23.5M),

meaning continuing GAAP losses are partially driven by SBC. Any

acceleration in SBC dilution beyond plan would compress per-share

metrics.

6. Concentration of Manufacturing Footprint. Production is

concentrated in three U.S. facilities: Vancouver, WA (semiconductor laser

diodes), Camas, WA (fiber laser modules), and Longmont, CO (high-energy

laser systems integration; 50,000 sq ft expansion completing 2026). A

disruption at any single site — including the in-progress Longmont

expansion creating temporary capacity loss — would materially impact

deliveries against the $162M funded backlog.

7. Talent Retention in Specialized Engineering Disciplines. High-power

laser engineering, photonics fabrication, and directed-energy systems

integration require specialized expertise. The labor market for these

disciplines is concentrated and competitive (Coherent, Lumentum,

Lockheed Martin Skunk Works, government labs). Talent loss to

competitors or government contractors carries material program execution

risk and intellectual property migration risk.

Filing URL: https://last10k.com/sec-filings/lasr/0001124796-26-000012.htm

Filing date: 2026-02-27